Related references
Note: Only part of the references are listed.Proton Pump Inhibitor-Related Gastric Mucosal Changes
Gwang Ha Kim
Gut and Liver (2020)
The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis
Ki-Nam Shim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2019)
Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences
Helge L. Waldum et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
Yoshikazu Kinoshita et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study
Yoon Jin Choi et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2017)
Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study
Xue Han et al.
CLINICAL DRUG INVESTIGATION (2015)
Rebamipide Improves Chronic Inflammation in the Lesser Curvature of the Corpus after Helicobacter pylori Eradication: A Multicenter Study
Tomoari Kamada et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Feasibility Study of a Systematic Approach for Discontinuation of Multiple Medications in Older Adults Addressing Polypharmacy
Doron Garfinkel et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Rebamipide: a gastrointestinal protective drug with pleiotropic activities
Yuji Naito et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Anti-inflammatory Effects of Rebamipide According to Helicobacter pylori Status in Patients with Chronic Erosive Gastritis: A Randomized Sucralfate-Controlled Multicenter Trial in China-STARS Study
Yiqi Du et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
An Open-Labeled Study of Rebamipide Treatment in Chronic Gastritis Patients with Dyspeptic Symptoms Refractory to Proton Pump Inhibitors
Taned Chitapanarux et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Preventive effects of rebamipide on NSAID-Induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers
Hyung-Keun Kim et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: A double-blind placebo-controlled study in Japan
Hiroto Miwa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy
M. Jalving et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
L. A. Garcia Rodriguez et al.
GUT (2006)
15th anniversary of rebamipide: Looking ahead to the new mechanisms and new applications
T Arakawa et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Review article: the long-term use of proton-pump inhibitors
AS Raghunath et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Bioequivalence of rebamipide granules and tablets in healthy adult male volunteers
S Hasegawa et al.
CLINICAL DRUG INVESTIGATION (2003)
Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis
K Haruma et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
A systematic review of the associations between dose regimens and medication compliance
AJ Claxton et al.
CLINICAL THERAPEUTICS (2001)
Share Paper
